张春阳

• 1:天津市第五中心医院

摘要(Abstract)：

目的探讨可能影响脑梗死患者静脉溶栓预后的因素。方法 69例急性脑梗死患者给予阿替普酶(recombi-nant tissue plasminogen activator,rt-PA)治疗,以90d时改良Rankin量表(mRS)评分作为疗效指标,0～1分者为预后良好,2～6分包括死亡为预后不佳,并对影响因素做Logistic回归分析。结果预后良好23例(33.3%),预后不良46例(66.67%)。经回归分析显示糖尿病、颈内或大脑中动脉闭塞为预后的独立预测因素。结论脑梗死合并糖尿病、颈内或大脑中动脉闭塞患者静脉溶栓预后不佳。

关键词(KeyWords)： 急性脑梗死;静脉溶栓;rt-PA;糖尿病

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 张春阳

参考文献(References)：

• [1]Lees KR,Bluhmki E,von Kummer R,et al.Time to treat-ment with intravenous alteplase and outcome in stroke:an up-dated pooled analysis of ECASS,ATLANTIS,NINDS,andEPITHET trials[J].Lancet,2010,375:1695-1703.
• [2]Hacke W,Kaste M,Bluhmki E,et al.Thrombolysis with alte-plase 3to 4.5hafter acute ischemic stroke[J].N Engl J Med,2008,359:1317-1329.
• [3]Paciaroni M,Caso V,Venti M,et al.Outcome in patients withstroke associated with internal carotid artery occlusion[J].Cerebro-vasc Dis,2005,20:108-113.
• [4]Saqqur M,Uchino K,Demchuk AM,et al.Site of arterial oc-clusion identified by transcranial Doppler predicts the responseto intravenous thrombolysis for stroke[J].Stroke,2007,38:948-954.
• [5]Rubiera M,Ribo M,Delgado-Mederos R,et al.Tandem inter-nal carotid artery/middle cerebral artery occlusion:An inde-pendent predictor of poor outcome after systemic thrombolysis[J].Stroke,2006,37:2 301-2 305.
• [6]Thomalla G,Kruetzelmann A,Siemonsen S,et al.Clinical andtissue response to intravenous thrombolysis in tandem internalcarotid artery/middle cerebral artery occlusion:an MRI study[J].Stroke,2008,39:1616-1618.
• [7]Marder VJ,Chute DJ,Starkman S,et al.Analysis of thrombiretrieved from cerebral arteries of patients with acute ischemicstroke[J].Stroke,2006,37:2 086-2 093.
• [8]Koga M,Toyoda K,Nakashima T,et al.Carotid duplex ultra-sonography can predict outcome of intravenous alteplase thera-py for hyperaute stroke[J].J Stroke Cerebrovasc Dis,2011,20(1):24-29.
• [9]Yong M,Kaste M.Dynamic of hyperglycemia as a predictor ofstroke outcome in the ECASS-II trial[J].Stroke,2008,39:2749-2 755.
• [10]Poppe AY,Majumdar SR,Jeerakathil T,et al.Canadian Alte-plase for Stroke Effectiveness Study Investigators.Admission hy-perglycemia predicts a worse outcome in stroke patients treatedwith intravenous thrombolysis[J].Diabetes Care,2009,32:617-622.
• [11]Anfossi G,Russo I,Trovati M.Resistance to aspirin andthienopyridines in diabetes mellitus and metabolic syndrome[J].Curr Vasc Pharmacol,2008,6:313-328.
• [12]Hacke W,Kaste M,Bluhmki E,et al.ECASS Invesgators.T-hrombolysis with alteplase 3to 4.5hours after acute ischemicstroke[J].N Engl J Med,2008,359:1317-1329.
• [13]Del Zoppo GJ,Saver JL,Jauch EC,et al.Expansion of thetime window for treatment of acute ischemic stroke with in-travenous tissue plasminogen activator:a science advisoryfrom the American Heart Association/American Stroke Asso-ciation association[J].Stroke,2009,40:2 945-2 948.
• [14]European Stroke Organisation(ESO)Executive Committee;ESO Writing Committee.Guidelines for management of is-chaemic stroke and transient ischaemic attack 2008[J].Cere-brovasc Dis,2008,25(5):457-507.
• [15]Shobha N,Buchan AM,Hill MD.Canadian Alteplase forStroke Effectiveness Study(CASES).Thrombolysis at 3-4.5hours after acute ischemic stroke onset-evidence from the Ca-nadian Alteplase for Stroke Effectiveness Study(CASES)registry[J].Cerebrovasc Dis,2011,31(3):223-228.
• [16]Kruetzelmann A,Khrmann M,Sobesky J,et al.Pretreatment dif-fusion-weighted imaging lesion volume predicts favorable outcomeafter intravenous thrombolysis with tissue-type plasminogen acti-vator in acute ischemic stroke[J].Stroke,2011,3:251-254.
• [17]Kimura K,Iguchi Y,Shibazaki K,et al.IV t-PA therapy in a-cute stroke patients with atrial fibrillation[J].J Neurol Sci,2009,276(1-2):6-8.
• [18]Kimura K,Iguchi Y,Yamashita S,et al.Atrial fibrillation asan independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke[J].J Neurol Sci,2008,267(1-2):57-61.